A new fractioning process to decrease the price of ranibizumab

Acta Ophthalmol. 2012 Dec;90(8):e645-6. doi: 10.1111/j.1755-3768.2012.02433.x. Epub 2012 Apr 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / economics*
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / economics*
  • Drug Compounding / economics*
  • Drug Costs*
  • Eye Diseases / drug therapy
  • Humans
  • Intravitreal Injections
  • Pharmaceutical Preparations / economics*
  • Ranibizumab

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Pharmaceutical Preparations
  • Ranibizumab